These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2193636)

  • 1. Effects of androgen treatment in impotent men with normal and low levels of free testosterone.
    Carani C; Zini D; Baldini A; Della Casa L; Ghizzani A; Marrama P
    Arch Sex Behav; 1990 Jun; 19(3):223-34. PubMed ID: 2193636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
    Carani C; Celani MF; Zini D; Baldini A; Della Casa L; Marrama P
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):284-8. PubMed ID: 2648724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.
    Morales A; Johnston B; Heaton JP; Lundie M
    J Urol; 1997 Mar; 157(3):849-54. PubMed ID: 9072584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate.
    Guay AT; Bansal S; Heatley GJ
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3546-52. PubMed ID: 8530597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Calculated Free Testosterone Overcome Total Testosterone in Protecting From Sexual Symptom Impairment? Findings of a Cross-Sectional Study.
    Boeri L; Capogrosso P; Ventimiglia E; Cazzaniga W; Pederzoli F; Moretti D; Dehò F; Montanari E; Montorsi F; Salonia A
    J Sex Med; 2017 Dec; 14(12):1549-1557. PubMed ID: 29198510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
    Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
    J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.
    Lima N; Cavaliere H; Knobel M; Halpern A; Medeiros-Neto G
    Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1433-7. PubMed ID: 11126339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone profiles after intramuscular injection of testosterone enanthate in patients with hypogonadism.
    Nakazawa R; Baba K; Nakano M; Katabami T; Saito N; Takahashi T; Iwamoto T
    Endocr J; 2006 Jun; 53(3):305-10. PubMed ID: 16710076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can testosterone level be a good predictor of late-onset hypogonadism?
    Heidari R; Sajadi H; Pourmand A; Pourmand G
    Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men.
    Abbasi AA; Drinka PJ; Mattson DE; Rudman D
    J Am Geriatr Soc; 1993 Sep; 41(9):975-82. PubMed ID: 8409184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.
    Moon DG; Park MG; Lee SW; Park K; Park JK; Kim SW; Park NC; Ahn TY; Paick JS; Seo JT; Yang DY; Lee JY; Kim JJ
    J Sex Med; 2010 Jun; 7(6):2253-2260. PubMed ID: 20345732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.